Trevi Therapeutics, Inc.
TRVI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001563880
In the last 90 days, Trevi Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 218 institutions reported holding it in 13F filings for Q2 2026, worth $2.76B in total; Viking Global Investors is the only superinvestor holding it.
13F holders, Q2 2026
Institutional positions in Trevi Therapeutics, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 218
- +22 vs. Q1 2026
- Shares held
- 149.0M
- +14.2M (+10.5%) vs. Q1 2026
- Total value
- $2.76B
- +$1.15B (+71.6%) vs. Q1 2026
- New holders
- 42
- 89 more added
- Sold out
- 20
- 59 more reduced
2 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TRVI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 218 | $2.76B |
| Q1 2026 | 198 | $1.61B |
| Q4 2025 | 184 | $1.63B |
| Q3 2025 | 164 | $1.18B |
| Q2 2025 | 154 | $627.2M |
| Q1 2025 | 137 | $554.3M |
| Q4 2024 | 110 | $329.5M |
| Q3 2024 | 93 | $194.1M |
| Q2 2024 | 77 | $166.6M |
| Q1 2024 | 80 | $177.9M |
| Q4 2023 | 63 | $70.0M |
| Q3 2023 | 55 | $106.1M |
| Q2 2023 | 53 | $116.7M |
| Q1 2023 | 36 | $80.4M |
| Q4 2022 | 37 | $83.3M |
| Q3 2022 | 40 | $70.5M |
| Q2 2022 | 32 | $80.8M |
| Q1 2022 | 23 | $32.9M |
| Q4 2021 | 17 | $10.3M |
| Q3 2021 | 18 | $17.4M |
| Q2 2021 | 17 | $28.1M |
| Q1 2021 | 19 | $35.6M |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Trevi Therapeutics, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Acorn Capital Advisors, LLC | 2,144,844 | $40.0M | 10.92% | 00.0% | Unchanged |
| Artia Global Partners LP | 2,210,852 | $41.2M | 7.84% | +197,250+9.8% | Added |
| Rubric Capital Management LP | 2,504,513 | $46.7M | 0.43% | −1,207,860−32.5% | Reduced |
| Eventide Asset Management, LLC | 2,660,000 | $49.6M | 0.66% | +37,694+1.4% | Added |
| Marshall Wace, LLP | 2,674,137 | $49.9M | 0.04% | −1,291,882−32.6% | Reduced |
| Geode Capital Management, LLC | 2,928,068 | $54.6M | 0.00% | +149,837+5.4% | Added |
| State Street Corp | 3,027,315 | $56.5M | 0.00% | +362,002+13.6% | Added |
| Frontier Capital Management Co LLC | 3,070,740 | $57.3M | 0.53% | +1,076,448+54.0% | Added |
| MPM Oncology Impact Management LP | 3,073,577 | $57.3M | 3.50% | −224,853−6.8% | Reduced |
| Vestal Point Capital, LP | 3,100,000 | $57.8M | 1.35% | +933,496+43.1% | Added |
| Woodline Partners LP | 4,081,333 | $76.1M | 0.24% | +3,080,551+307.8% | Added |
| Vivo Capital, LLC | 5,094,668 | $95.0M | 8.68% | 00.0% | Unchanged |
| Vanguard Capital Management LLC | 5,530,675 | $103.1M | 0.00% | +552,108+11.1% | Added |
| Wellington Management Group LLP | 5,684,592 | $106.0M | 0.02% | +495,504+9.5% | Added |
| Frazier Life Sciences Management, L.P. | 9,939,447 | $185.4M | 4.04% | −1000.0% | Reduced |
| BlackRock, Inc. | 11,155,026 | $208.0M | 0.00% | +914,840+8.9% | Added |
| FMR LLC | 12,562,839 | $234.3M | 0.01% | +4,524,778+56.3% | Added |
| NEA Management Company, LLC | 13,222,228 | $246.6M | 15.53% | 00.0% | Unchanged |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −1,201,489−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −570,971−100.0% | Sold out |
| GMT Capital Corp | 0 | $0 | 0.00% | −317,700−100.0% | Sold out |
| Propel Bio Management, LLC | 0 | $0 | 0.00% | −223,802−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −103,967−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −79,859−100.0% | Sold out |
| Simplify Asset Management Inc. | 0 | $0 | 0.00% | −65,412−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −38,415−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −28,149−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −25,930−100.0% | Sold out |
| IMC-Chicago, LLC | 0 | $0 | 0.00% | −24,324−100.0% | Sold out |
| Diadema Partners LP | 0 | $0 | 0.00% | −21,663−100.0% | Sold out |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −16,101−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −11,770−100.0% | Sold out |
| SIH Partners, LLLP | 0 | $0 | 0.00% | −10,001−100.0% | Sold out |
| Federation des caisses Desjardins du Quebec | 0 | $0 | 0.00% | −4,300−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −789−100.0% | Sold out |
| Versant Capital Management, Inc | 0 | $0 | 0.00% | −232−100.0% | Sold out |
| Twin Peaks Wealth Advisors, LLC | 0 | $0 | 0.00% | −29−100.0% | Sold out |
| Swiss Life Asset Management Ltd | 0 | $0 | 0.00% | −21,428−100.0% | Sold out |
| Janus Henderson Group PLC | – | – | – | – | Not filed |
| CWM, LLC | – | – | – | – | Not filed |